1. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial. Issue 4 (28th February 2022) Authors: Ajjan, R A; Hensor, E M A; Del Galdo, F; Shams, K; Abbas, A; Fairclough, R J; Webber, L; Pegg, L; Freeman, A; Taylor, A E; Arlt, W; Morgan, A W; Tahrani, A A; Stewart, P M; Russell, D A; Tiganescu, A Journal: European journal of endocrinology Issue: Volume 186:Issue 4(2022) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗